Two standards of care for HIV: Why are Africans being short-changed?

Retrovirology

Volumn 6, Issue , 2009, Pages

  Wainberg, Mark A ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ETRAVIRINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICAN; BODY DEFORMITY; CD4 LYMPHOCYTE COUNT; CROSS RESISTANCE; DEFORMITY; DEVELOPING COUNTRY; DISEASE COURSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; EDITORIAL; ETHNIC GROUP; FACE DEFORMITY; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SOUTH AFRICA; VIRUS REPLICATION; AFRICA; HEALTH CARE QUALITY; IMMUNOLOGY; STANDARD; VIROLOGY;

AFRICA; ANTI-HIV AGENTS; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; QUALITY OF HEALTH CARE;

EID: 71949130658     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-109     Document Type: Editorial

References (10)

1. Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP, Yeni P. Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial. AIDS 2002, 16(18):2447-54. 10.1097/00002030-200212060-00010, 12461419.
2. Doualla-Bell F, Avalos A, Brenner B, Gaolathe T, Mine M, Gaseitsiwe S, Oliveira M, Moisi D, Ndwapi N, Moffat H, Essex M, Wainberg MA. High Prevalence of the K65R Mutation in Human Immunodeficiency Virus Type 1 Subtype C-Infected Batswana Patients Treated with ddI-based regimens. Antimicrob Agents Chemother 2006, 50(12):4182-5. 1693987, 17015626, 10.1128/AAC.00714-06.
3. Hosseinipour MC, van Oosterhout JJ, Weigel R, Phiri S, Kamwendo D, Parkin N, Fiscus SA, Nelson JA, Eron JJ, Kumwenda J. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS 2009, 23(9):1127-34. 10.1097/QAD.0b013e32832ac34e, 19417582.
4. Invernizzi CF, Coutsinos D, Oliveira M, Moisi D, Brenner BG, Wainberg MA. Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype C. J Infect Dis 2009, 200(8):1202-6. 10.1086/605894, 19764886.
5. Vingerhoets J, Peeters M, Azijn H, Tambuyzer L, Hoogstoel A, Nijs N, de Bethune MP, Picchio G. An update of the list of NNRTI mutations associated with decreased virological response to etravirine (ETR): multivariate analysis on the pooled DUET-1 and DUET-2 clinical trial data. Antivir Ther 2008, 13(Suppl 3):A26.
6. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, Jacobson LP, Rodriguez B, Sterling TR, Kirk GD, Napravnik S, Rachlis AR, Calzavara LM, Horberg MA, Silverberg MJ, Gebo KA, Goedert JJ, Benson CA, Collier AC, Van Rompaey SE, Crane HM, McKaig RG, Lau B, Freeman AM, Moore RD, . NA-ACCORD Investigators Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009, 360(18):1815-26. 10.1056/NEJMoa0807252, 19339714.
7. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, Meehan MO, Lutalo T, Gray RH. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000, 342(13):921-9. 10.1056/NEJM200003303421303, 10738050.
8. Wainberg MA. HIV transmission should be decriminalized: HIV prevention programs depend on it. Retrovirology 2008, 5:108. 2613399, 19046412, 10.1186/1742-4690-5-108.
9. Byakika-Tusiime J, Chinn LW, Oyugi JH, Obua C, Bangsberg DR, Kroetz DL. Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults. PLoS One 2008, 3(12):e3981. 2602850, 19096711, 10.1371/journal.pone.0003981.
10. Jeang KT. World AIDS Day 2007: AIDS at 26, are we there yet?. Retrovirology 2007, 4:86. 2169258, 18053150, 10.1186/1742-4690-4-86.